Serum Institute of India Archives | Page 2 of 6

News Reports

Serum Institute’s COVID-19 vaccine Covovax gets WHO approval for emergency use

OpIndia Staff - 17 December, 2021

Covovax, a vaccine developed by SII and US-based Novovax, became the 9th Covid-19 vaccine to be approved by the WHO

News Reports

On PM Modi’s birthday, India achieves record vaccination numbers, 2.5 crore doses in a single day

OpIndia Staff - 17 September, 2021

India shattered its own vaccination record on PM Modi’s 71st birthday, jabbing more than 2 crore vaccine doses in a single day

News Reports

Had to ‘fall at the feet’ of bureaucrats to get permissions: Serum Institute chairman Cyrus Poonawalla says no ‘maska polish’ required under PM Modi

OpIndia Staff - 14 August, 2021

Serum Institute chairman Cyrus Poonawalla recalls the governmental and bureaucratic hurdles he faced during the UPA regime

News Reports

Serum Institute of India to commence production of Russia’s Sputnik V vaccine from September: Details

OpIndia Staff - 13 July, 2021

The Serum Institute of India has already received cell and vector samples from Russia's Gamaleya Centre and the cultivation process has begun

News Reports

Covishield excluded from EU’s Green Pass: Adar Poonawalla says talking to European regulators and countries for clearance

OpIndia Staff - 28 June, 2021

Covishield vaccine is manufactured by the Serum Institute of India and developed by Oxford-AstraZeneca. AstraZeneca's EU-made vaccine Vaxzervria is included in the Green Pass.

News Reports

Serum Institute of India all set to manufacture Novavax’s COVID-19 vaccine Covovax, trial data demonstrates 90.4 overall efficacy

OpIndia Staff - 16 June, 2021

Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals

World

France President Emmanuel Macron slams Joe Biden administration for blocking vaccine raw material export to India

OpIndia Staff - 11 June, 2021

French President Emmanuel Macron took potshots at the Joe Biden administration for blocking export of Covod-19 raw materials.

News Reports

Not just indemnity, Pfizer wants disputes over vaccine supply under jurisdiction of US courts only, Indian govt in dilemma

OpIndia Staff - 7 June, 2021

The indemnity clause protects the company (in this case Pfizer) from any financial liability in case of legal disputes.

News Reports

How the Congress government backstabbed the Serum Institute of India during the swine flu epidemic

Dibakar Dutta - 28 May, 2021

Forced by circumstances, the Serum Institute of India had moved the Delhi High Court in June 2012 under section 9 of the Arbitration Act.

Media Fact-Check

Fact-check: Has govt of India not placed any new orders for coronavirus vaccines since March 2021? Here are the facts

OpIndia Staff - 3 May, 2021

Detailed account of advance given for vaccines for both, COVISHIELD as well as COVAXIN and the number of doses received was put forth by the government of India.

Serum Institute of India

Latest News

Recently Popular

About us

Follow us